Company · CIK 0001806540
Lycia Therapeutics, Inc.
LYCASearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$32.83+$1.39 (+4.42%)
LYCA · Last trade
- Prev close
- $31.44
- Range (20d)
- $25.05 – $32.83
On the record
Recent filings
- 8-KLYCACurrent report0001628280-26-067312 · 443.2 KBSEC(opens sec.gov)
- S-1/ALYCALycia Therapeutics, Inc.0001628280-26-066381 · 15.8 MBSEC(opens sec.gov)
- S-1LYCAIPO registration0001628280-26-064973 · 17.1 MBSEC(opens sec.gov)
Insiders
- Bachrodt AmyChief Financial Officer, 10% Owner
- Bertozzi Carolyn R10% Owner
- ELI LILLY & Co10% Owner
- Fischer LaurentDirector
- Henderson JaneDirector
- Koh Bong Y10% Owner
- Lee Chin HyokChief Medical Officer, 10% Owner
- RIEFLIN WILLIAM JLDirector
- Shah Nimish P10% Owner
- Trombley Aetna WunDirector, President and CEO, 10% Owner
Tickers
Addresses
business
400 EAST JAMIE COURT, SUITE 200
SOUTH SAN FRANCISCO, CA, 94080
mailing
400 EAST JAMIE COURT, SUITE 200
SOUTH SAN FRANCISCO, CA, 94080
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies